Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidate

Citations of this article
Mendeley users who have this article in their library.


The field isolate of porcine epidemic diarrhea virus (PEDV) was serially passaged in Vero cells. The cell passaged PEDV, designated KPEDV-9, was tested for its pathogenicity in the neonatal pigs, immunogenicity and safety in the pregnant sows. The result indicated that KPEDV-9 at the 93rd passage revealed reduced pathogenicity in the neonatal pigs. Pregnant sows inoculated with the attenuated virus showed increased immune responses by ELISA. In addition, delivered piglets were protected from challenge of wild type PEDV. The safety test in pregnant sows indicated that all inoculated animals farrowed the average numbers of litters of piglets. The results of this study supported that the attenuated virus derived from serial passage could be applied as vaccine for protecting suckling piglets against PEDV infection.




Kweon, C. H., Kwon, B. J., Lee, J. G., Kwon, G. O., & Kang, Y. B. (1999). Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidate. Vaccine, 17(20–21), 2546–2553.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free